Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Sesterhenn

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
JAMA|October 25, 1995
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American menJ W Moul, I A Sesterhenn, R R Connelly, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 3, 1998
Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumoursA Heidenreich, N S Schenkman, I A Sesterhenn, et al.
Oncogene|December 26, 2001
A novel human cancer culture model for the study of prostate cancerY Yasunaga, K Nakamura, D Ko, et al.
The Journal of Urology|July 20, 1999
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patientsJ W Moul, R R Connelly, R M Mooneyhan, et al.
Journal of Clinical Pathology|June 17, 2008
Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?B Furusato, I L Rosner, D Osborn, et al.
Cancer|March 1, 1997
Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomyJ J Bauer, R R Connelly, I A Sesterhenn, et al.
Cancer Research|June 1, 1994
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancersJ P Gaddipati, D G McLeod, H B Heidenberg, et al.
The Journal of Urology|February 25, 2000
Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancerL L Xu, V Srikantan, I A Sesterhenn, et al.
Surgery|August 1, 1996
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancerJ W Moul, M C Bettencourt, I A Sesterhenn, et al.
International Journal of Epidemiology|May 23, 2001
Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, ChinaJ V Lacey, J Deng, M Dosemeci, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
JAMA|October 25, 1995
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American menJ W Moul, I A Sesterhenn, R R Connelly, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 3, 1998
Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumoursA Heidenreich, N S Schenkman, I A Sesterhenn, et al.
Oncogene|December 26, 2001
A novel human cancer culture model for the study of prostate cancerY Yasunaga, K Nakamura, D Ko, et al.
The Journal of Urology|July 20, 1999
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patientsJ W Moul, R R Connelly, R M Mooneyhan, et al.
Journal of Clinical Pathology|June 17, 2008
Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?B Furusato, I L Rosner, D Osborn, et al.
Cancer|March 1, 1997
Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomyJ J Bauer, R R Connelly, I A Sesterhenn, et al.
Cancer Research|June 1, 1994
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancersJ P Gaddipati, D G McLeod, H B Heidenberg, et al.
The Journal of Urology|February 25, 2000
Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancerL L Xu, V Srikantan, I A Sesterhenn, et al.
Surgery|August 1, 1996
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancerJ W Moul, M C Bettencourt, I A Sesterhenn, et al.
International Journal of Epidemiology|May 23, 2001
Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, ChinaJ V Lacey, J Deng, M Dosemeci, et al.
Pageof 11